LXEO- Lexeo Therapeutics, Inc.

Name: Lexeo Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lexeo Therapeutics, Inc. (LXEO) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. LXEO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Townsend Richard Nolan	395.1K	$2.30M	-
COO	Otero Jose Manuel	131.4K	$766.0K	-
Other	Adler Eric	72.6K	$423.5K	-
Other	Robertson Jenny	68.4K	$398.7K	-
Other	See Tai Sandi	65.5K	$381.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 18, 2025	Otero Jose Manuel	Chief Technical Officer	Sell	2,848	$4.67	$13,294.46	-4.5%	+92.7%	-
Aug 18, 2025	Robertson Jenny	Chief Legal Officer	Sell	542	$4.67	$2,530.06	-0.9%	+92.7%	-
Aug 18, 2025	Adler Eric	Chief Medical Officer	Sell	608	$4.67	$2,838.14	-0.9%	+92.7%	-
Aug 18, 2025	Townsend Richard Nolan76	Chief Executive Officer	Sell	2,735	$4.67	$12,766.98	-1.2%	+92.7%	-
Aug 18, 2025	See Tai Sandi	Chief Development Officer	Sell	382	$4.67	$1,783.18	-0.6%	+92.7%	-
May 16, 2025	Townsend Richard Nolan76	Chief Executive Officer	Sell	1,074	$2.77	$2,979.28	-0.5%	+47.8%	-
May 16, 2025	Adler Eric	Chief Medical Officer	Sell	585	$2.77	$1,622.79	-0.9%	+47.8%	-
May 16, 2025	Robertson Jenny	Chief Legal Officer	Sell	521	$2.77	$1,445.25	-0.8%	+47.8%	-
May 16, 2025	See Tai Sandi	Chief Development Officer	Sell	367	$2.77	$1,018.06	-0.6%	+47.8%	-
Feb 19, 2025	Robertson Jenny	Chief Legal Officer	Sell	2,101	$4.41	$9,271.71	-3.5%	-20.9%	+40.6%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC